The Path Forward: Navigating the DSCSA Stabilization Policy
Learn more about the ins and outs of the new DSCSA stabilization policy, delaying some facets of DSCSA implementation to November 2024.
Elizabeth Gallenagh, JD, general counsel and senior vice president of supply chain integrity at the Healthcare Distribution Alliance, Tish Pahl, JD, principal at Olsson Frank Weeda Terman Matz PC, and Scott Mooney, vice president of distribution operations at McKesson, discussed the FDA’s Drug Supply Chain Security Act (DSCSA) stabilization policy, which delays some facets of DSCSA implementation to November 2024.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
